The Medical Letter on Drugs and Therapeutics
Renal Sympathetic Denervation for Hypertension
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Renal sympathetic denervation is under investigation as a therapeutic option for hypertension that has not responded to ≥3 antihypertensive drugs (resistant hypertension).1

MECHANISM OF ACTION — Activation of efferent renal sympathetic nerves results in increased norepinephrine release, increased renin secretion, increased sodium and fluid reabsorption, and decreased renal blood flow and glomerular filtration rate. In addition, excitatory afferent nerves from the kidney stimulate central sympathetic nervous system activation.

Bilateral renal denervation has been shown to decrease systemic blood pressure in animals, and decades ago, surgical sympathectomy was shown to improve blood pressure and outcomes in hypertensive patients,2 but it was abandoned with the advent of effective antihypertensive drug therapy. ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Renal Sympathetic Denervation for Hypertension
Article code: 1394c
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian